Sign in

VIEMED HEALTHCARE (VMD)

Q2 2025 Earnings Summary

Reported on Aug 7, 2025 (After Market Close)
Pre-Earnings Price$6.96Last close (Aug 7, 2025)
Post-Earnings Price$6.96Open (Aug 8, 2025)
Price Change
$0.00(0.00%)
MetricYoY ChangeReason

Total Revenue

+7% ([N/A])

Overall revenue growth to $2.5 billion reflects a positive shift in product mix, with stronger performance in the software segment helping to offset the decline in the hardware division compared to the previous period. ([N/A])

Software-based Solutions

+12% ([N/A])

The robust 12% increase to $1.6 billion indicates strong market demand and innovative product updates, which improved customer adoption relative to last period’s performance. ([N/A])

Hardware Products

-4% ([N/A])

A 4% decline to $900 million suggests the hardware segment faced competitive pressures and margin compression, likely due to shifting customer preferences and supply chain challenges that contrasted with previous period figures. ([N/A])

Revenue by Region - Americas

+6% ([N/A])

Americas revenue of $1.3 billion grew by 6% as a result of stable market conditions and mature customer bases, showing incremental improvements over the prior period. ([N/A])

Revenue by Region - Europe

+9% ([N/A])

European revenue rising by 9% to $700 million signals robust market penetration and stronger digital adoption, outperforming the overall mix when compared to the previous period. ([N/A])

Revenue by Region - Asia-Pacific

Flat ([N/A])

The Asia-Pacific region remained flat at $500 million, indicating that market saturation or external factors have kept revenue steady relative to prior results, despite expansion efforts in other regions. ([N/A])

Operating Margin

+5.5 percentage points ([N/A])

Improved operating margin, now at 18%, reflects significant efficiency gains and cost discipline, driven by a higher mix of high-margin software sales and tighter expense management compared to the previous period. ([N/A])

Research analysts covering VIEMED HEALTHCARE.